Home > Quotes > WCG > Guru Analysis > Kenneth Fisher

Kenneth Fisher Guru Analysis for WellCare Health Plans, Inc.

WCG 
$83.66
*  
0.82
0.99%
Get WCG Alerts
*Delayed - data as of Dec. 26, 2014 12:35 ET  -  Find a broker to begin trading WCG now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    WCG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Assessments & Analysis Based on December 24, 2014 close price: $82.84

  for the Price/Sales Investor based on the criteria of Kenneth Fisher. Return to WCG Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 0%
Benjamin Graham 29%
Validea 21%
Motley Fool 45%
David Dreman 36%
Martin Zweig 46%
Kenneth Fisher 30%
James P. O'Shaughnessy 50%



Detailed Analysis

Guru Score: 30%


PRICE/SALES RATIO: [PASS]

The prospective company should have a low Price/Sales ratio. Cyclical companies with Price/Sales ratios below or equal to .4 are tremendous values and should be sought. WCG's P/S ratio of 0.30 Based on trailing 12 month sales, is below .4 which is considered very favorable. It passes this methodology's P/S ratio test with flying colors.


TOTAL DEBT/EQUITY RATIO: [FAIL]

Less debt equals less risk according to this methodology. WCG's Debt/Equity of 56.89% is unacceptable, thus failing the test.


PRICE/RESEARCH RATIO: [PASS]

This methodology considers companies in the Technology and Medical sectors to be attractive if they have low Price/Research ratios. WCG is neither a Technology nor Medical company. Therefore the Price/Research ratio is not available and, hence, not much emphasis should be placed on this particular variable.


PRELIMINARY GRADE: No Interest in WCG At this Point

Is WCG a "Super Stock"? NO


Price/Sales Ratio: [PASS]

The Price/Sales ratio is the most important variable according to this methodology. The prospective company should have a low Price/Sales ratio. WCG's Price/Sales ratio of 0.30 passes this criterion.


LONG-TERM EPS GROWTH RATE: [FAIL]

This methodology looks for companies that have an inflation adjusted EPS growth rate greater than 15%. WCG's inflation adjusted EPS growth rate of -3.16% does not pass this test.


FREE CASH PER SHARE: [PASS]

This methodology looks for companies that have a positive free cash per share. Companies should have enough free cash available to sustain three years of losses. This is based on the premise that companies without cash will soon be out of business. WCG's free cash per share of 2.66 passes this criterion.


THREE YEAR AVERAGE NET PROFIT MARGIN: [FAIL]

This methodology looks for companies that have an average net profit margin of 5% or greater over a three year period. WCG's three year net profit margin, which averages 2.89%, does not pass this criterion.

 
The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru's published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.

The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities' officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer
The Validea Market Legends ETF (VALX)